The estimated Net Worth of Stacey M Stevens is at least $1.6 Milión dollars as of 5 January 2022. Ms. Stevens owns over 17,006 units of Icad Inc stock worth over $214,932 and over the last 18 years she sold ICAD stock worth over $829,985. In addition, she makes $559,069 as President at Icad Inc.
Stacey has made over 19 trades of the Icad Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently she bought 17,006 units of ICAD stock worth $104,927 on 5 January 2022.
The largest trade she's ever made was exercising 33,676 units of Icad Inc stock on 12 September 2008 worth over $57,249. On average, Stacey trades about 4,365 units every 84 days since 2006. As of 5 January 2022 she still owns at least 154,627 units of Icad Inc stock.
You can see the complete history of Ms. Stevens stock trades at the bottom of the page.
Stacey M. Stevens serves as President of the Company since March 2019. From February 2016 to March 2019, Ms. Stevens served as the Company’s Executive Vice President, Chief Strategy and Commercial Officer, and from June 2006 to February 2016, she served as the Company’s Senior Vice President of Marketing and Strategy. Prior to joining iCAD, Ms. Stevens held a number of sales, business development, and marketing management positions with Philips Medical Systems, Agilent Technologies, Inc. and Hewlett Packard’s Healthcare Solutions Group (which was acquired in 2001 by Philips Medical Systems). From February 2005 to June 2006, she was Vice President, Marketing Planning at Philips Medical Systems, where she was responsible for the leadership of all global marketing planning functions for Philips’ Healthcare Business. From 2003 to January 2005, she was Vice President of Marketing for the Cardiac and Monitoring Systems Business Unit of Philips, where she was responsible for all marketing and certain direct sales activities of Philips America’s Field Operations. Prior to that, Ms. Stevens held several key marketing management positions in the Ultrasound Business Unit of Hewlett-Packard/Agilent and Philips Medical Systems. Ms. Stevens earned a Bachelor of Arts Degree in Political Science from the University of New Hampshire, and an MBA from Boston University’s Graduate School of Management.
As the President of Icad Inc, the total compensation of Stacey Stevens at Icad Inc is $559,069. There are 1 executives at Icad Inc getting paid more, with Michael S. Klein having the highest compensation of $621,021.
Stacey Stevens is 52, she's been the President of Icad Inc since 2019. There are 10 older and 1 younger executives at Icad Inc. The oldest executive at Icad Inc is Michael S. Klein, 67, who is the Exec. Chairman & CEO.
Stacey's mailing address filed with the SEC is C/O ICAD, INC., 98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH, 03062.
Over the last 22 years, insiders at Icad Inc have traded over $10,970,060 worth of Icad Inc stock and bought 704,596 units worth $1,672,448 . The most active insiders traders include Anthony F Ecock, Nathaniel Dalton a Kevin C Burns. On average, Icad Inc executives and independent directors trade stock every 45 days with the average trade being worth of $39,056. The most recent stock trade was executed by Dana R Brown on 31 March 2023, trading 40,000 units of ICAD stock currently worth $52,000.
icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and computed tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com.
Icad Inc executives and other stock owners filed with the SEC include: